Alibaba (BABA) Pays $600 Million in DOJ Drug Probe

Alibaba Group Holding Limited (NYSE:BABA) shares fell 1.89% to 96.14 dollars after the company and its U.S. payment affiliate, AUS Merchant Services, agreed to pay 600 million dollars to settle Justice Department allegations tied to illegal pharmaceutical sales on its platforms.

What the Settlement Covers

Non prosecution agreements announced Wednesday resolve claims that Alibaba and AUS violated the Federal Food, Drug, and Cosmetic Act by allowing merchants to ship illegal drugs, controlled substances, regulated chemicals, and pill presses into the United States through Alibaba.com and AliExpress.com. Alibaba acknowledged roughly 80,000 prohibited transactions between January 2016 and December 2024, with gross merchandise value exceeding 200 million dollars. Undercover agents made more than 40 purchases of banned pharmaceuticals and counterfeiting equipment to build the case, according to the department.

Court filings note that internal staff had flagged doubts about the adequacy of platform safeguards even as formal policies against restricted goods stayed in place. Investigators also pointed to private in platform messaging that some sellers used to arrange deals, occasionally steering buyers toward encrypted third party apps to finish transactions.

AUS Merchant Services and the Payment Side of the Case

AUS Merchant Services, a subsidiary of Ant Group formerly known as Alipay U.S., admitted that weaknesses in its anti money laundering controls let certain merchants push prohibited transactions through its payment rails. Wire transfer data was not always integrated into its monitoring systems, the department said, which left suspicious activity from high risk jurisdictions unchecked. At least one seller reportedly continued shipping banned goods to U.S. buyers even after AUS had already flagged and reported that account.

Alibaba's portion of the penalty totals 325 million dollars, split between 125 million in criminal fines and 200 million in forfeiture. AUS will pay 85 million in criminal fines plus 190 million in forfeited funds. Both companies agreed to rebuild compliance programs and stay engaged with prosecutors going forward.

Alibaba Valuation, Momentum and Yield

The stock's 96.14 dollar price sits well below its 52 week high of 146.87 and closer to the 91.99 low, putting shares near the bottom third of that range. Market capitalization stands at 230.70 billion dollars, and the dividend yield is 1.09%, a modest cushion for holders during a legal overhang. The RSI reading of 24.03 indicates oversold conditions by conventional technical thresholds, suggesting selling pressure has outpaced recent fundamentals.

The bull case rests on valuation compression: a stock trading near multi year lows with an RSI this depressed has, in past cycles, drawn buyers betting on mean reversion once legal uncertainty clears. The settlement, while costly, removes an open ended liability and lets management redirect attention to core commerce and cloud operations. The bear case centers on reputational risk tied to compliance failures spanning nearly a decade, regulatory scrutiny that could extend beyond this case, and a dividend yield too thin to offset further downside if sentiment stays negative.

Where Compliance Reform Goes From Here

Assistant Attorney General Brett A. Shumate said online marketplace operators, domestic or foreign, must build safeguards against bad actors or face accountability. Both Alibaba and AUS now operate under agreements requiring compliance overhauls and continued cooperation with federal prosecutors, leaving open how quickly those changes translate into investor confidence.